Company news
Kangmei Pharmaceutical Co., Ltd news in 2024
Kangmei Pharmaceutical Co., Ltd's news releases, calls and decks from 2024, newest first.
Announcement on Resolution of the 1st Extraordinary General Meeting in 2024
November 15, 2024
Announcement on Risk Warning in Stock Trading
November 11, 2024
Announcement on Abnormal Fluctuations in Stock Trading
November 8, 2024
Announcement on Convening the Q3 2024 Performance Briefing
November 7, 2024
Announcement on Resolutions of the 3rd Extraordinary Meeting of the 9th Board of Supervisors in 2024
October 30, 2024
Announcement on Progress of Litigation Enforcement by Subsidiaries (III)
October 8, 2024
Announcement on Convening the 2024 Semi-annual Performance Briefing
September 5, 2024
Announcement on Resolution of the 6th Meeting of 9th Board of Supervisors
August 23, 2024
Announcement on Progress of Litigation Enforcement by Subsidiaries (II)
August 19, 2024
Announcement on Progress of Litigation Enforcement by Subsidiaries
August 6, 2024
Announcement on Expected Gains in Semi-annual Performance for 2024
July 12, 2024
Announcement on the Removal of Other Risk Warnings for the Stock and Suspension of Trading
July 2, 2024
Announcement on Resolutions of 3rd Special Session of 9th Board of Directors of 2024
June 26, 2024
Announcement on Reply to "Letter of Supervision on Information Disclosure of 2023 Annual Report of Kangmei Pharmaceutical Co.,Ltd" from SSE
May 27, 2024
Announcement on Receiving Enforcement Decree from Court
May 17, 2024
Announcement on Convening Performance Meeting for 2023 and 1st Quarter of 2024
May 9, 2024
Announcement on Resolutions of 2023 Annual General Meeting
May 8, 2024
Announcement on Resolution of 2nd Special Session of 9th Board of Directors of 2024
April 29, 2024
Notice on Convening 2023 Annual General Meeting
April 12, 2024